Asimia is no longer available in the United States.
Asimia (paroxetine mesylate) is prescribed to treat generalized anxiety disorder, major depressive disorder, obsessive-compulsive disorder, and panic disorder. Asimia is a selective serotonin uptake inhibitor, which means that it balances the serotonin in the brain to help with mood and anxiety issues. Dose strength of Asimia varies depending on the disorder being treated; it could range anywhere from 10 to 60 mg. Paroxetine mesylate is also used in the brand Pexeva.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.